Form 4: NEONC Chief Clinical Officer Buys Shares

NEONC Technologies Holdings' Chief Clinical Officer, Yousha Neman-Ebrahim, purchased 1,100 shares of common stock at $6.69 per share.

Summary

• Yousha Neman-Ebrahim, Chief Clinical Officer of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI), acquired 1,100 shares of common stock.
• The transaction occurred on November 20, 2025, at a price of $6.69 per share.
• Following this purchase, Neman-Ebrahim directly owns 134,260 shares of NEONC TECHNOLOGIES HOLDINGS, INC. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged acquisition.

Sentiment

Score: 7

Explanation: The insider purchase by a key officer suggests confidence in the company's future, which is generally a positive signal for investors.

Positives

• An insider, the Chief Clinical Officer, purchased shares, which can be seen as a vote of confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned acquisition rather than a reactive one.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The Chief Clinical Officer, Yousha Neman-Ebrahim, acquired common stock of NEONC TECHNOLOGIES HOLDINGS, INC., which constitutes a related party transaction between an insider and the company's securities.

Stakeholder Impact

• Shareholders: The insider purchase by a high-ranking officer may be interpreted as a positive signal, potentially boosting investor confidence and perception of the company's value.

Key Dates

Recommendation

The purchase of company stock by a key officer, the Chief Clinical Officer, signals management's confidence in NEONC TECHNOLOGIES HOLDINGS, INC.'s future prospects. While this is a positive indicator, a single insider transaction, without additional comprehensive financial or strategic context, typically supports a 'hold' recommendation rather than a strong buy or sell, as it reinforces existing positions or suggests stability.

Keywords

NEONC TECHNOLOGIES HOLDINGS, NTHI, Insider Trading, Stock Purchase, Yousha Neman-Ebrahim, Chief Clinical Officer, Form 4, Equity Acquisition